Growing attention is being given to the public health dimensions of perinatal mood and anxiety disorders (PMADs). Previously, we have reviewed studies looking at the prevalence of screening for PMADs and disparities therein and [...]
The American College of Obstetricians and Gynecologists (ACOG) now recommends screening for perinatal depression and anxiety, stating that “clinicians screen patients at least once during the perinatal period for depression and anxiety symptoms using [...]
Perinatal mood and anxiety disorders (PMADs) including prenatal depression (PND) and postpartum depression (PPD) can have a profound adverse impact on the well-being of mothers, newborns, and entire families. It is estimated that 20%-25% [...]
A recently published article in the American Journal of Public Health has attributed a substantial financial cost to untreated perinatal mood and anxiety disorders among mothers. The study, conducted by researchers with the think [...]
![By Vera Kratochvil [Public domain], via Wikimedia Commons](https://womensmentalhealth.org/wp-content/uploads/2015/06/Mother_Kissing_Baby-320x202.jpg)
According to a new study from the Centers for Disease Control and Prevention (CDC), more than 15 percent of reproductive-aged women filled a prescription for an antidepressant medication during the years 2008–2013.  The prevalence of [...]
One of the goals of the Affordable Care Act (ACA) is to improve women’s access to health care. In the past, women could be denied insurance coverage because they were women or could be charged more for insurance than their male counterparts.
